Document is current

Any future updates will be listed below

Correction: Cost‑effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands

Crossref DOI link: https://doi.org/10.1186/s12933-025-02752-2

Published Online: 2025-05-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark